The GLP-1 weight loss drugs revolutionizing the treatment of obesity, diabetes and a slew of other diseases come with a major ...
Variants in GLP‑1 and GIP receptor genes partly determine weight loss and nausea risk on GLP‑1 drugs, signaling a shift from ...
Social media posts about glucagon-like peptide-1 receptor agonists may identify patient concerns not captured in clinical trials, according to a study published ...
One mom was left unsettled after nearly a year of her young children experiencing random vomiting episodes, with no clear explanation for the distressing situation. She couldn't shake the feeling that ...
Cannabis use may impact glycemic control by impairing self-management behaviors and delaying gastric emptying among patients ...
Dr. Elise Herman outlines common household hazards that can harm children—from cleaning products to medications and ...
While taking a GLP-1, certain behaviours can worsen side effects or inhibit the benefits you receive. Here's what to avoid.
Rezdiffra (resmetirom) is a brand-name drug prescribed for a type of liver disease called metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH) ...
Reproductive symptoms, temperature-related complaints, and psychiatric symptoms are among the side effects of GLP-1s reported ...
From higher cancer risk to possible fetal abnormalities, Kolkata doctors weigh in on the pros and cons of pre-wedding ...
A foreign visitor in her 60s has tested positive for meningococcal meningitis, Taiwan’s fifth case this year, the Centers for ...